454 related articles for article (PubMed ID: 21305276)
1. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes.
Greenbaum J; Sidney J; Chung J; Brander C; Peters B; Sette A
Immunogenetics; 2011 Jun; 63(6):325-35. PubMed ID: 21305276
[TBL] [Abstract][Full Text] [Related]
2. In silico identification of supertypes for class II MHCs.
Doytchinova IA; Flower DR
J Immunol; 2005 Jun; 174(11):7085-95. PubMed ID: 15905552
[TBL] [Abstract][Full Text] [Related]
3. The Utility of Supertype Clustering in Prediction for Class II MHC-Peptide Binding.
Shen WJ; Zhang X; Zhang S; Liu C; Cui W
Molecules; 2018 Nov; 23(11):. PubMed ID: 30463372
[TBL] [Abstract][Full Text] [Related]
4. Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires.
Sidney J; Southwood S; Sette A
Immunogenetics; 2005 Jul; 57(6):393-408. PubMed ID: 16003466
[TBL] [Abstract][Full Text] [Related]
5. HLA class I supertypes: a revised and updated classification.
Sidney J; Peters B; Frahm N; Brander C; Sette A
BMC Immunol; 2008 Jan; 9():1. PubMed ID: 18211710
[TBL] [Abstract][Full Text] [Related]
6. HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM.
van Lith M; McEwen-Smith RM; Benham AM
J Biol Chem; 2010 Dec; 285(52):40800-8. PubMed ID: 20959457
[TBL] [Abstract][Full Text] [Related]
7. Peptide binding predictions for HLA DR, DP and DQ molecules.
Wang P; Sidney J; Kim Y; Sette A; Lund O; Nielsen M; Peters B
BMC Bioinformatics; 2010 Nov; 11():568. PubMed ID: 21092157
[TBL] [Abstract][Full Text] [Related]
8. Characterizing the binding motifs of 11 common human HLA-DP and HLA-DQ molecules using NNAlign.
Andreatta M; Nielsen M
Immunology; 2012 Jul; 136(3):306-11. PubMed ID: 22352343
[TBL] [Abstract][Full Text] [Related]
9. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR, DQ and DP typing using PCR amplification and immobilized probes.
Erlich H; Bugawan T; Begovich AB; Scharf S; Griffith R; Saiki R; Higuchi R; Walsh PS
Eur J Immunogenet; 1991; 18(1-2):33-55. PubMed ID: 2069944
[TBL] [Abstract][Full Text] [Related]
11. The HLA molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 share an extensive overlap in peptide binding specificity.
Sidney J; del Guercio MF; Southwood S; Sette A
J Immunol; 2002 Nov; 169(9):5098-108. PubMed ID: 12391226
[TBL] [Abstract][Full Text] [Related]
12. Differential distribution of HLA-DQ beta/DR beta epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with susceptibility to and protection from AIDP.
Magira EE; Papaioakim M; Nachamkin I; Asbury AK; Li CY; Ho TW; Griffin JW; McKhann GM; Monos DS
J Immunol; 2003 Mar; 170(6):3074-80. PubMed ID: 12626563
[TBL] [Abstract][Full Text] [Related]
13. Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing.
Zhou Z; Reyes-Vargas E; Escobar H; Chang KY; Barker AP; Rockwood AL; Delgado JC; He X; Jensen PE
Eur J Immunol; 2017 Feb; 47(2):314-326. PubMed ID: 27861808
[TBL] [Abstract][Full Text] [Related]
14. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex.
Djilali-Saiah I; Benini V; Daniel S; Assan R; Bach JF; Caillat-Zucman S
Tissue Antigens; 1996 Aug; 48(2):87-92. PubMed ID: 8883297
[TBL] [Abstract][Full Text] [Related]
15. Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity.
Sidney J; Steen A; Moore C; Ngo S; Chung J; Peters B; Sette A
J Immunol; 2010 Mar; 184(5):2492-503. PubMed ID: 20139279
[TBL] [Abstract][Full Text] [Related]
16. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules.
Falk K; Rötzschke O; Stevanović S; Jung G; Rammensee HG
Immunogenetics; 1994; 39(4):230-42. PubMed ID: 8119729
[TBL] [Abstract][Full Text] [Related]
17. A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population.
McKinney DM; Southwood S; Hinz D; Oseroff C; Arlehamn CS; Schulten V; Taplitz R; Broide D; Hanekom WA; Scriba TJ; Wood R; Alam R; Peters B; Sidney J; Sette A
Immunogenetics; 2013 May; 65(5):357-70. PubMed ID: 23392739
[TBL] [Abstract][Full Text] [Related]
18. HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity.
Castelli FA; Buhot C; Sanson A; Zarour H; Pouvelle-Moratille S; Nonn C; Gahery-Ségard H; Guillet JG; Ménez A; Georges B; Maillère B
J Immunol; 2002 Dec; 169(12):6928-34. PubMed ID: 12471126
[TBL] [Abstract][Full Text] [Related]
19. Motif analysis of HLA class II molecules that determine the HPV associated risk of cervical carcinogenesis.
Odunsi K; Ganesan T
Int J Mol Med; 2001 Oct; 8(4):405-12. PubMed ID: 11562779
[TBL] [Abstract][Full Text] [Related]
20. Epithelial expression of HLA class II antigens and Fc gamma receptors in patients with adult periodontitis.
Nunes IP; Johannessen AC; Matre R; Kristoffersen T
J Clin Periodontol; 1994 Sep; 21(8):526-32. PubMed ID: 7527433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
